Cargando…

Correction to: The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome

Detalles Bibliográficos
Autores principales:	Krysiak, Robert, Szkróbka, Witold, Okopień, Bogusław
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460562/ https://www.ncbi.nlm.nih.gov/pubmed/34036550 http://dx.doi.org/10.1007/s43440-021-00276-6

Ejemplares similares

The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2020)

Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
por: Krysiak, Robert, et al.
Publicado: (2023)

Vitamin D Status Determines Cardiometabolic Effects of Cabergoline in Women with Elevated Prolactin Levels: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

The impact of hypotestosteronemia on cardiometabolic effects of atorvastatin in men with hypercholesterolemia: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2021)

Vitamin D Status Determines the Impact of Metformin on Gonadotropin Levels in Postmenopausal Women
por: Krysiak, Robert, et al.
Publicado: (2023)

Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic Effects of Atorvastatin: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2022)

Sexual Function and Depressive Symptoms in Young Women with Euthyroid Hashimoto’s Thyroiditis Receiving Vitamin D, Selenomethionine and Myo-Inositol: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

The impact of rosuvastatin on hypothalamic–pituitary–testicular axis activity in metformin-treated and metformin-naïve men with low testosterone levels: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2021)

Myo-Inositol Potentiates the Inhibitory Effect of Metformin on Prolactin Levels
por: Krysiak, Robert, et al.
Publicado: (2023)

Cardiometabolic profile of young women with hypoprolactinemia
por: Krysiak, Robert, et al.
Publicado: (2022)

Pleiotropic Effects of Atorvastatin and Fenofibrate in Metabolic Syndrome and Different Types of Pre-Diabetes
por: Krysiak, Robert, et al.
Publicado: (2010)

Cardiometabolic Effects of Cabergoline and Combined Oral Contraceptive Pills in Young Women with Hyperprolactinemia: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

Cardiometabolic Risk Factors in Rosuvastatin-Treated Men with Mixed Dyslipidemia and Early-Onset Androgenic Alopecia
por: Krysiak, Robert, et al.
Publicado: (2021)

Correction: Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS)
por: Barrea, Luigi, et al.
Publicado: (2023)

Cardiometabolic risk in polycystic ovary syndrome
por: Bajuk Studen, Katica, et al.
Publicado: (2018)

The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome
por: Sathyapalan, Thozhukat, et al.
Publicado: (2017)

Correction to: Neuroendocrine characteristics of induced pluripotent stem cells from polycystic ovary syndrome women
por: Min, Zheying, et al.
Publicado: (2019)

Rosuvastatin Potentiates Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
por: Moin, Abu Saleh Md, et al.
Publicado: (2021)

Correction to: Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome
por: Ou, Huang-Tz, et al.
Publicado: (2018)

The impact of exogenous vitamin D on thyroid autoimmunity in euthyroid men with autoimmune thyroiditis and early-onset androgenic alopecia
por: Krysiak, Robert, et al.
Publicado: (2021)

Correction to: Troxerutin protects against DHT-induced polycystic ovary syndrome in rats
por: Gao, Zixuan, et al.
Publicado: (2020)

The Effect of Metformin on Plasma Prolactin Levels in Young Women with Autoimmune Thyroiditis
por: Krysiak, Robert, et al.
Publicado: (2023)

Coexistence of primary aldosteronism and Hashimoto’s thyroiditis
por: Krysiak, Robert, et al.
Publicado: (2011)

Effects of atorvastatin on the insulin resistance in women of polycystic ovary syndrome: A systematic review and meta-analysis
por: Chen, Lin-Lin, et al.
Publicado: (2021)

Correction: Should All Women with Polycystic Ovary Syndrome Be Screened for Metabolic Parameters?: A Hospital-Based Observational Study
por: Li, Hui, et al.
Publicado: (2017)

Impaired Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women with Autoimmune Thyroiditis: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2023)

Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women
por: Baldani, Dinka Pavicic, et al.
Publicado: (2015)

Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
por: van der Ham, Kim, et al.
Publicado: (2023)

The Role of Different Methods in Defining Cardiometabolic Risk and Metabolic Syndrome in Women with Polycystic Ovary Syndrome
por: Çakır Biçer, Nihan, et al.
Publicado: (2023)

Correction to: The effects of statins on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
por: Chen, Jianguo, et al.
Publicado: (2022)

Correction to “Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome”
Publicado: (2023)

Visceral Adiposity Index: Simple Tool for Assessing Cardiometabolic Risk in Women with Polycystic Ovary Syndrome
por: Agrawal, Hiya, et al.
Publicado: (2019)

Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2016)

Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome
por: Torres Fernandez, Edgar D, et al.
Publicado: (2018)

Recurrent pancreatitis induced by hyperparathyroidism in pregnancy
por: Krysiak, Robert, et al.
Publicado: (2010)

Pleiotropic Action of Short-Term Metformin and Fenofibrate Treatment, Combined With Lifestyle Intervention, in Type 2 Diabetic Patients With Mixed Dyslipidemia
por: Pruski, Maciej, et al.
Publicado: (2009)

The effect of short-term metformin treatment on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2014)

Impaired metabolic effects of metformin in men with early-onset androgenic alopecia
por: Krysiak, Robert, et al.
Publicado: (2021)

Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome
por: Pruett, Jacob E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b54mlbg846p15qi06fbtnljep3